Company to host investor conference call and webcast on Monday, November 17th, at 9:00am ESTPITTSBURGH, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), an AI-driven drug ...

The 30th UN Climate Conference has opened in Belém. The world meets in a burning forest to discuss how to stop the fire. For ...

Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q3 2025 Earnings Call Transcript November 12, 2025 Atea Pharmaceuticals, Inc.

Operator: Good afternoon, ladies and gentlemen, and welcome to the CytoSorbents Corp. Third Quarter 2025 Earnings Conference ...

Record quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established Ongoing efficiency ...

The 'soft background check' was based on names and not fingerprints, resulting in the DUI conviction of another person ...

Precigen, Inc. ( PGEN) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good afternoon, ladies and gentlemen, and welcome to the Precigen Third Quarter 2025 Financial Results and Business Update ...

Immigrant caregivers for the sick and elderly are losing legal status, deepening a labor shortage in NJ health care fields.

Tonix prepares for the November 2025 launch of Tonmya with 3Q25 revenue growth, strong cash, higher SG&A, and a robust ...

Vitamin D sits at the intersection of bone, muscle, immune health, and overall metabolism. Researchers have asked a simple ...

Q3 2025 Earnings Call Transcript November 13, 2025 Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is $-1.40538, expectations were $-1.91. Operator: Good morning, ladies and ...

For the quarter ended September 30, 2025, the Company reported a net loss applicable to common stockholders of $8.2 million, or ($0.13) per share, compared to a net loss applicable to common ...